Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Borentain

Showing results (11-20 of 67) with videos related to

Pageof 7
Sort By:
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|August 7, 2009
Concurrent autochthonous acute hepatitis E and hepatitis B reverse seroconversion in an HIV-1-infected patient: one virus may hide anotherPhilippe Colson, René Gérolami, Jacques Moreau, et al.
Clinics and Research in Hepatology and Gastroenterology|January 2, 2020
Hepatitis Delta recurrence post-liver transplantation in absence of detectable hepatitis B surface antigen and hepatitis B virus DNA in peripheral bloodPaul Rémi Petit, Patrick Borentain, Sarah Aherfi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 16, 2005
Fulminant hepatitis B associated with a specific insertion in the basal core promoter region of hepatitis B virus DNA after immunosuppressive treatmentRené Gérolami, Mireille Henry, Patrick Borentain, et al.
British Journal of Haematology|August 20, 2008
Entecavir as a first-line treatment for HBV reactivation following polychemotherapy for lymphomaPhilippe Colson, Patrick Borentain, Diane Coso, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|July 19, 2011
Treatment of severe acute hepatitis E by ribavirinRené Gerolami, Patrick Borentain, Ferdaous Raissouni, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 27, 2007
Efficacy of hepatitis B virus (HBV) vaccination in treating lamivudine-resistant HBV reactivation following hepatitis B surface antigen seroconversionRené Gérolami, Patrick Borentain, Philippe Colson, et al.
Clinics and Research in Hepatology and Gastroenterology|December 1, 2018
Hepatitis E virus infection in heart transplant recipients, Southeastern FranceLéa Luciani, Pierre Deharo, Sarah Aherfi, et al.
International Journal of Antimicrobial Agents|July 30, 2016
Evolution of hepatitis E virus-associated meningo-polyradiculoneuropathy on ribavirinMarine Sicello, Amandine Sevy, Patrick Borentain, et al.
Hepatology (Baltimore, Md.)|September 30, 2015
Recombinant hepatitis C viruses that might hamper accurate genotype classification and choice of treatment with direct-acting agents, southeastern FrancePhilippe Colson, Patrick Borentain, Catherine Dhiver, et al.
Hepatology (Baltimore, Md.)|September 6, 2017
Hepatocellular carcinoma complicating hepatitis E virus-related cirrhosisPatrick Borentain, Philippe Colson, Emilie Bolon, et al.
Pageof 7

Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|August 7, 2009
Concurrent autochthonous acute hepatitis E and hepatitis B reverse seroconversion in an HIV-1-infected patient: one virus may hide anotherPhilippe Colson, René Gérolami, Jacques Moreau, et al.
Clinics and Research in Hepatology and Gastroenterology|January 2, 2020
Hepatitis Delta recurrence post-liver transplantation in absence of detectable hepatitis B surface antigen and hepatitis B virus DNA in peripheral bloodPaul Rémi Petit, Patrick Borentain, Sarah Aherfi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 16, 2005
Fulminant hepatitis B associated with a specific insertion in the basal core promoter region of hepatitis B virus DNA after immunosuppressive treatmentRené Gérolami, Mireille Henry, Patrick Borentain, et al.
British Journal of Haematology|August 20, 2008
Entecavir as a first-line treatment for HBV reactivation following polychemotherapy for lymphomaPhilippe Colson, Patrick Borentain, Diane Coso, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|July 19, 2011
Treatment of severe acute hepatitis E by ribavirinRené Gerolami, Patrick Borentain, Ferdaous Raissouni, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 27, 2007
Efficacy of hepatitis B virus (HBV) vaccination in treating lamivudine-resistant HBV reactivation following hepatitis B surface antigen seroconversionRené Gérolami, Patrick Borentain, Philippe Colson, et al.
Clinics and Research in Hepatology and Gastroenterology|December 1, 2018
Hepatitis E virus infection in heart transplant recipients, Southeastern FranceLéa Luciani, Pierre Deharo, Sarah Aherfi, et al.
International Journal of Antimicrobial Agents|July 30, 2016
Evolution of hepatitis E virus-associated meningo-polyradiculoneuropathy on ribavirinMarine Sicello, Amandine Sevy, Patrick Borentain, et al.
Hepatology (Baltimore, Md.)|September 30, 2015
Recombinant hepatitis C viruses that might hamper accurate genotype classification and choice of treatment with direct-acting agents, southeastern FrancePhilippe Colson, Patrick Borentain, Catherine Dhiver, et al.
Hepatology (Baltimore, Md.)|September 6, 2017
Hepatocellular carcinoma complicating hepatitis E virus-related cirrhosisPatrick Borentain, Philippe Colson, Emilie Bolon, et al.
Pageof 7